Induction regimens for transplant-eligible patients with newly diagnosed multiple myeloma: a network meta-analysis of randomized controlled trials

Overview of attention for article published in Cancer Management and Research, July 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source

twitter: 2 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 43 Mendeley

Summary News Policy documents X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 15,390 followers.

In the absence of other modern therapies, VTD, VTDC and TAD have a role for induction in Ndx SCT-eligible #myeloma https://t.co/NhH8G2Nrws

Reply Repost Favourite

Meta-analysis finds VTD, VTDC, & TAD regimens most beneficial byORR, OS, and PFS for transplant-eligible #myeloma: https://t.co/HzoG8Y3P3y. https://t.co/zTuRDyBFsY

Reply Repost Favourite